Daewoong pharmaceutical Co.,Lt...
KOSE:A069620
111,500.00
+ ₩1,800.00 (1.64%)
111,500.00
+ ₩1,800.00 (1.64%)
End-of-day quote: 05/14/2024

Daewoong pharmaceutical Co.,Ltd financials at a glance

The revenue of Daewoong pharmaceutical Co.,Ltd is reported as 1222 billion Won in the fiscal year 2023. The earnings were 9760 Won per share in 2023, which was 122.48 higher than 2022. And about 26.32879 billion Won are reported as free cash flow in the financials of Daewoong pharmaceutical Co.,Ltd 2023. Dividends of 600 Won per share were paid to shareholders of Daewoong pharmaceutical Co.,Ltd stock KOSE:A069620 in fiscal 2023.

₩1.22T
Revenue
₩9.76k
Earnings Per Share
49.96%
Gross Margin %
₩82.83B
Free Cash Flow
Revenue
1,222,000.00
Earnings Per Share
9,760.00
Gross Margin %
49.96
Free Cash Flow
82,831.12

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue N/A ₩1.22T ₩1.16T ₩1.06T ₩944.75B ₩1.01T ₩943.52B ₩866.76B ₩794.01B ₩800.52B ₩727.22B ₩674.87B ₩678.84B ₩711.11B ₩613.75B ₩547.67B ₩484.24B ₩400.44B ₩338.17B ₩281.54B ₩248.42B
GM % Gross Margin % 49.94% 49.96% 49.85% 47.18% 42.26% 42.88% 39.65% 42.29% 42.07% 35.91% 36.61% 42.54% 41.10% 42.12% 44.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
OM Operating Margin 7.94% 8.81% 7.48% 7.71% 1.61% 4.01% 2.68% 4.00% 2.93% 5.19% 6.73% 10.46% 5.51% 8.40% 14.28% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share ₩4.10k ₩9.76k ₩4.39k ₩3.25k ₩294.00 ₩1.96k ₩144.00 ₩3.56k ₩3.20k ₩4.77k ₩3.08k ₩5.69k ₩2.81k ₩5.16k ₩4.66k ₩2.70k ₩5.26k ₩4.31k ₩3.00k ₩2.18k ₩1.22k
Div. Dividends N/A ₩600.00 ₩640.00 ₩600.00 ₩600.00 ₩600.00 ₩600.00 ₩600.00 ₩600.00 ₩700.00 ₩700.00 ₩800.00 ₩800.00 ₩754.08 ₩697.76 ₩646.95 ₩669.99 ₩650.47 ₩569.16 ₩548.84 ₩508.18
PR % Payout Ratio % 0 6.15% 14.59% 18.44% 204.08% 30.61% 416.67% 16.86% 18.78% 14.68% 22.73% 14.07% 28.52% 14.63% 14.96% 23.97% 12.75% 15.09% 18.94% 25.14% 41.64%
Sha. Shares N/AM 11.51M 11.07M 11.07M 10.76M 10.32M 10.32M 10.32M 10.32M 10.32M 10.32M 10.32M 10.02M 10.02M 9.81M 10.62M 10.89M 10.89M 11.08M 12.45M 11.8M
OCF Operating Cash Flow N/A ₩135.67B ₩104.91B ₩47.95B ₩98.36B ₩37.99B ₩53.76B ₩63.30B ₩13.71B ₩37.60B ₩59.18B ₩54.58B ₩46.70B ₩78.28B ₩93.91B ₩0.00M ₩0.00M ₩0.00M ₩0.00M ₩0.00M ₩0.00M
FCF Free Cash Flow N/A ₩82.83B ₩66.30B ₩27.76B ₩77.28B ₩18.88B ₩1.11B ₩4.74B ₩-,106,910.83M ₩-36,284.37M ₩13.17B ₩35.54B ₩22.00B ₩33.76B ₩65.73B ₩0.00M ₩0.00M ₩0.00M ₩0.00M ₩0.00M ₩0.00M
FCFS Free Cash Flow Per Share ₩3.83k ₩-1,717.20 ₩556.72 ₩-3,155.69 ₩4.10k ₩870.98 ₩-,858.70 ₩722.80 ₩-14,252.63 ₩-5,905.76 ₩-2,209.36 ₩3.45k ₩1.30k ₩3.01k ₩-1,459.58 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00